STOCK TITAN

Legend Biotech to Host R&D Day on October 18, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Legend Biotech Corporation (NASDAQ: LEGN) will host its first Research & Development Day on October 18, starting at 10:00 a.m. (Eastern Time), at Andaz 5th Avenue, New York. The event will showcase updates on their advancing pipeline for hematological and oncological indications, including their BCMA clinical development program. Presentations will be made by senior leaders, including CEO Ying Huang and CSO Frank Fan. A live webcast will be available on the Legend Biotech website, with recordings accessible for six months.

Positive
  • None.
Negative
  • None.

SOMERSET, N.J.--(BUSINESS WIRE)-- Legend Biotech Corporation (NASDAQ: LEGN), a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications, will host its first Research & Development Day on Monday, October 18, commencing at 10:00 a.m. (Eastern Time), at Andaz 5th Avenue in New York.

The meeting will feature updates on the company’s advancing pipeline of hematological and oncological indications and expanding cell therapy capabilities, including its B cell maturation antigen (BCMA) clinical development program. Presentations will be delivered by Legend’s senior leadership team:

  • Ying Huang, PhD, Chief Executive Officer and Chief Financial Officer
  • Frank Fan, MD, PhD, Chief Scientific Officer
  • Steve Gavel, Vice President, US & Europe Commercial
  • Lida Pacaud, MD, Vice President, Clinical Development

A live webcast and presentation will be available to investors and other interested parties on the Legend Biotech website under “Events and Presentations”. A recording of the webcast can be viewed as early as 24 hours after the event and will be archived for six months.

To register for the event, please visit this link.

About Legend Biotech

Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. Our team of over 900 employees across the United States, China and Europe, along with our differentiated technology, global development, and manufacturing strategies and expertise, provide us with the strong potential to discover, develop, and manufacture best-in-class cell therapies for patients in need. We are engaged in a strategic collaboration to develop and commercialize our lead product candidate, cilta-cel, an investigational BCMA-targeted CAR-T cell therapy for patients living with multiple myeloma. This candidate is currently being studied in registrational clinical trials.

Investor Contacts:

Jessie Yeung, Head of Corporate Finance and Investor Relations, Legend Biotech

jessie.yeung@legendbiotech.com or investor@legendbiotech.com

Crystal Chen, Manager of Investor Relations and Corporate Communications, Legend Biotech

crystal.chen@legendbiotech.com

Press Contact:

Tina Carter, Corporate Communications Lead, Legend Biotech

tina.carter@legendbiotech.com

(908) 331-5025

Source: Legend Biotech

FAQ

What is the date and time of Legend Biotech's Research & Development Day?

Legend Biotech's Research & Development Day is on October 18 at 10:00 a.m. Eastern Time.

Where will Legend Biotech's R&D Day take place?

The R&D Day will be held at Andaz 5th Avenue, New York.

What topics will be covered during Legend Biotech's R&D Day?

The event will cover updates on the company's pipeline for hematological and oncological indications, particularly the BCMA clinical development program.

Who will present at Legend Biotech's Research & Development Day?

Presentations will be delivered by CEO Ying Huang, CSO Frank Fan, and other senior leaders.

How can I access the webcast of Legend Biotech's R&D Day?

The webcast will be available on the Legend Biotech website under 'Events and Presentations'.

Is there a recording of Legend Biotech's R&D Day available?

Yes, a recording will be available for viewing 24 hours after the event and archived for six months.

Legend Biotech Corporation American Depositary Shares

NASDAQ:LEGN

LEGN Rankings

LEGN Latest News

LEGN Stock Data

7.41B
181.05M
1.31%
51.22%
8.61%
Biotechnology
Healthcare
Link
United States of America
Somerset